Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Christina Koehler, Sebastian Werth, MD, Vera Gelbricht, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Maria Eulitz, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 2267.

https://doi.org/10.1182/blood.V120.21.2267.2267

Published: 2012

Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Sebastian Werth, MD, Christina Koehler, Vera Gelbricht, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 1156.

https://doi.org/10.1182/blood.V120.21.1156.1156

Published: 2012

Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Christina Koehler, Sebastian Werth, MD, Ulrike Haensel, Thomas Schreier, Maria Eulitz, Luise Tittl, Ines Beyer-Westendorf, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 1159.

https://doi.org/10.1182/blood.V120.21.1159.1159

Published: 2012

Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Sebastian Werth, MD, Christina Koehler, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 502.

https://doi.org/10.1182/blood.V120.21.502.502

Published: 2012

Journal Articles

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Vera Gelbricht, Christina Koehler, Sebastian Werth, MD, Ulrike Haensel, Thomas Schreier, Tittl Luise, Maria Eulitz, Ines Beyer-Westendorf, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 1173.

https://doi.org/10.1182/blood.V120.21.1173.1173

Published: 2012

NARROW

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Email alerts

ASH Publications

American Society of Hematology

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only